ABMD
$266.43
Abiomed
($1.78)
(.66%)
ABMD
Earnings Whisper ®
N/A
3rd Quarter December 2020
Consensus:  $1.11
Revenue:  $229.71 Mil
Thursday
Jan 28
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ABMD reports earnings?
Beat
Meet
Miss

Where is ABMD's stock price going from here?
Up
Flat
Down
Stock chart of ABMD
Analysts
Summary of analysts' recommendations for ABMD
Score
Grade
Pivots
Resistance
$276.17
$274.42
$271.31

$269.56

Support
$266.45
$264.70
$261.59
Tweet
Growth
Description
Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company'sproducts are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWatersIntegra LifeSciences HoldingsCardiovascular Systems3MTeleflex